KC-0137

T47D-P95ERBB2-Cell-Line

19903

Home » 细胞系 » T47D-P95ERBB2-Cell-Line

Background of T47D-P95ERBB2-Cell-Line

HER2, also named ERBB2, is a cell-surface receptor tyrosine kinase, ERBB2 overexpression or overactivity have associated with a number of cancers, especially the breast cancer. The identification of ERBB2 as a driver gene has led to the development of anticancer therapeutics agents, including lapatinib, Neratinib and Herceptin.

Specifications

Catalog Number	KC-0137
Cell Line Name	T47D-P95ERBB2-Cell-Line
Host Cell Line	Human T-47D cell line
Description	Stable T47D clone expressing exogenous HER2 gene with extracellular domain deletion
Quantity	Two vials of frozen cells (≥2-10⁶/vial)
Stability	Stable in culture over a minimum of 10 passages
Application	Drug screening and biological assays
Freezing Medium	70% RPMI1640+20% FBS+10% DMSO
Propagation Medium	RPMI1640+10%FBS+0.2 Units/mL Insulin+500µg/mL G418
Selection Marker	Neomycin
Morphology	Epithelial
Subculture	Split saturated culture 1:3-1:5 every 3 days; seed out at about 1-3 × 10⁵ cells/mL
Incubation	37 °C with 5% CO₂
Storage	Liquid nitrogen immediately upon receiving
Doubling Time	Approximately 30 hours
Mycoplasma Status	Negative
In Vivo Validation	NA

Cell Line Generation

T47D P95HER2 cell Line was generated using Retroviral vector expressing human P95HER2 sequence.

Characterization

Figure: Characterization of HER2 and its mutants overexpressing in T47D stable clones using Western Blot.

Cell Resuscitation

Prewarm culture medium (RPMI1640 + 10% FBS + 0.2Units/mL Insulin + 500µg/mL G418)in a 37°C water bath.
Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
Incubate the flask at 37°C, 5% CO₂ incubator.
Split saturated culture 1:3-1:5 every 3 days; seed out at about 1-3 × 10⁵ cells/mL.

Cell Freezing

Prepare the freezing medium (70% RPMI-1640 + 20% FBS + 10% DMSO) fresh immediately before use.
Keep the freezing medium on ice and label cryovials.
Transfer cells to a sterile, conical centrifuge tube, and count the cells.
Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
Resuspend the cells at a density of at least 3×10⁶ cells/mL in chilled freezing medium.
Aliquot 1 mL of the cell suspension into each cryovial.
Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
Transfer vials to liquid nitrogen for long-term storage

References

Wang, Shizhen Emily, Archana Narasanna, Marianela Perez-Torres, Bin Xiang, Frederick Y Wu, Seungchan Yang, Graham Carpenter, Adi F Gazdar, Senthil K Muthuswamy, and Carlos L Arteaga. 2006. ¡ùHER2 Kinase Domain Mutation Results in Constitutive Phosphorylation and Activation of HER2 and EGFR and Resistance to EGFR Tyrosine Kinase Inhibitors..¡ì Cancer Cell 10 (1). Elsevier: 25Ã¿38.
Robichaux, Jacqulyne P, Yasir Y Elamin, Zhi Tan, Brett W Carter, Shuxing Zhang, Shengwu Liu, Shuai Li, et al. 2018. ¡ùMechanisms and Clinical Activity of an EGFR and HER2 Exon 20Ã¿Selective Kinase Inhibitor in NonÃ¿Small Cell Lung Cancer.¡ì Nature Medicine, April. Springer US, 1Ã¿15.